Representatives of Brussels-based offices leading the work of Health Working Group.
ERRIN’s Health Working Group (WG) supports members with early intelligence and regular updates about EU-level health policy-related issues, regulations, EU programmes and their funding opportunities. Creating opportunities for interregional cooperation in the Health area is one of the WG’s main objectives. The WG is also a vehicle for networking, profile raising and promoting good practices and projects among health stakeholders in the ERRIN regions.
The topic of widening gathers high attention in the discussions around the next European Framework Programme for R&I, raising questions with the potential to influence not only the Widening sub-
The Health Working Group meeting will update colleagues on the European Commission’s initiatives linked to staff and skills shortages and training and up-skilling of the health workforce, exploring
ERRIN has been closely involved in the design and implementation of the EU Missions since their inception. Missions remain one of the network's priorities and were one of the four main areas of focus
This year is the bicentennial of the birth of the father of genetics, Gregor Johann Mendel. To pay tribute to this pre-eminent scientist of the 19th century, Mendel Genetics Conference will take place between 20–23 July, 2022, in Brno, the city where Mendel spent a substantial part of his life, and where he laid the foundations of genetics.
As one of the first events in its programme, the Czech Presidency of the Council of the EU will organise a flagship conference "Synergies in the Research and Innovation Funding in Europe" on 7-8 July 2022 in Prague. The conference shall be held as a physical event, but following web streaming will be available. Pre-registration is obligatory.
ERRIN's Spring Annual General Meeting will be held this year on 23 June at 15:00-17:30 CEST followed by a networking cocktail from 18:00 CEST. In addition to discussing formal issues and offering an opportunity to network, the event will feature debates around the new European Innovation Agenda.
In the frame of the French Presidency of the Council of the EU, Aviesan and INCA are organising a meeting on the Horizon Europe Mission on Cancer.
Following the legislative proposal for the European Health Data Space and in anticipation of the Health Data Regulation, the Health and ICT Working Groups will come together to explore outstanding questions ranging from the financial and legislative, to the conceptual and practical.
The Innovative Health Initiative (IHI) will launch its first calls for proposals in June 2022. In anticipation of this, the partnership has published draft versions of the calls and is preparing a one-day, hybrid brokerage event in Brussels on 14 June.
The ERRIN Year in review 2022 is out! Read the report to see the numerous activities ERRIN and its members have been involved in throughout the year.
Please find attached ERRIN and the network of European Regional and Local Health Authorities (EUREGHA)'s joint statement on the Horizon Europe Mission on Cancer.
Further to the Health WG meeting on the Cancer Mission, EUREGHA and ERRIN have decided to address the Cancer Mission Board with a statement to emphasise the role of regions in this mission.
Autumn 2023 marked the start of ERRIN’s targeted reflections on regional dimension in research and innovation in the new EU Multiannual Financial Framework post-2027, relating to the next EU Framework Programme for R&I (FP10) and future cohesion policy. We are offering a recap of our activities so far, first messages and planned next steps.
Health Technology lab (Turku UAS) and Turku PET Center are seeking the opportunity to join a consortium for the IHI call HORIZON-JU-IHI-2023-05-04 Maximising the potential of synthetic data generation in healthcare applications.
Following the call for nominations for ERRIN Management Board held between 20 September and 5 October, we are happy to announce the nominated Management Board members. The five nominees will be approved as new Management Board members at the ERRIN Extraordinary General Meeting on 16 November.
In view of the annual strategy workshops that we will organise with all the Working Group (WG) and Task Force (TF) leaders in the second half of November, all members are invited to provide input on priorities, topics, and activities that should be addressed in 2024. The input can be provided by 31 October 2023.
On 19 September 2023, the European Commission published the list of actions that Member States and Associated Countries to Horizon Europe are so far undertaking or planning to undertake in support of one or more of the five flagships of the New European Innovation Agenda, including Flagship 3 closely followed by ERRIN. 20 countries have so far reported 169 actions in total, with their scope ranging from regional, through national to European.
Every year ERRIN holds elections for the Management Board. Becoming a member of the Board offers a great opportunity to develop ERRIN further and strategically lead the network’s activities. You can put forward your candidature for this year’s elections until 5 October.
A 2-day training course is organised on “Evidence informed policymaking” which will aim to introduce participants to useful tools, train them to navigate between different types of evidence and research methods, and reflect on how to deal with the many challenges of evidence-informed policymaking. ERRIN has been invited to nominate up to 3 candidates.
EIT Health announces its two Wild Card challenges for an investment of up to €2 million. This year the challenges are women's health and digital therapeutics.
Partners from Finland, Denmark, Estonia, Sweden and Malta are sought for a VET TNE project.
I2M is looking for organisations working in specific areas of elderly care for a matchmaking event in February.
The consortium aims to develop a multifunctional antibacterial wound dressing that will be relevant for tissue regeneration of diabetic foot ulcers. Our objective is the four-fold integration in a single wound dressing of potent antibacterial, wound exudate and malodour secretions absorbing and regenerative actions.
The EIP on AHA has an open call for organisations who have successfully implemented an AHA innovation - the I2M Adoption Awards. Applications are open until 20th December 2019.